INMED PHARMACEUTICALS INC (INMXXXX)
Institutional ownership reported to the SEC as of Q2 2022, across 7 quarters.
8
Reporting holders
$514.5K
Reported value
0.0%
Held as options
-4
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $450.0K | 956,118 | 0.01% | new | NEW |
| RENAISSANCE TECHNOLOGIES LLC | $23.0K | 49,700 | 0.00% | 3q | +10.0%+$2.1K |
| TWO SIGMA ADVISERS, LP | $23.0K | 48,281 | 0.00% | 3q | -68.8%-$50.6K |
| GEODE CAPITAL MANAGEMENT, LLC | $6.0K | 13,905 | 0.00% | 2q | HELD |
| CITADEL ADVISORS LLC | $6.0K | 12,966 | 0.00% | new | NEW |
| Creative Planning | $5.0K | 10,832 | 0.00% | 7q | HELD |
| TD Waterhouse Canada Inc. | $1.3K | 2,130 | 0.00% | 3q | HELD |
| Federation des caisses Desjardins du Quebec | $240 | 511 | 0.00% | 7q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2022 | 8 | $514.5K | 1,094,443 | 2 | 1 | 1 | 0.0% |
| Q1 2022 | 12 | $341.9K | 361,670 | 4 | 1 | 2 | 0.0% |
| Q4 2021 | 11 | $536.4K | 408,410 | 5 | 0 | 2 | 0.0% |
| Q3 2021 | 11 | $980.9K | 559,272 | 2 | 2 | 2 | 0.0% |
| Q2 2021 | 13 | $3.0M | 944,275 | 1 | 4 | 4 | 0.0% |
| Q1 2021 | 16 | $1.6M | 466,621 | 5 | 4 | 0 | 0.0% |
| Q4 2020 | 11 | $137.9K | 41,592 | 10 | 0 | 0 | 0.0% |